{arrow_up} Back to top

Risk Minimisation Materials

Search by company, common medicine name, or title of Risk Minimisation Material

Isotretinoin

Ennogen IP Ltd

{pdf_link}

Isotretinoin Soft Capsules Acknowledgement of Risk Form

{healthcare_pro_orange} For Healthcare Professionals

Isotretinoin-GB-RMM-ARF Ver 1.0 September 2025 MHRA Approval Date: September 2025


{pdf_link}

Isotretinoin Soft Capsules Patient Reminder Card

{healthcare_pro_orange} For Healthcare Professionals

Isotretinoin-GB-RMM- PRC Ver 1.0 September 2025 MHRA Approval Date: September 2025


{pdf_link}

Isotretinoin Soft Capsules Pharmacist Checklist

{healthcare_pro_orange} For Healthcare Professionals

Isotretinoin-GB-RMM- PC Ver 1.0 September 2025 MHRA Approval Date: September 2025


Ranbaxy (UK) Limited a Sun Pharmaceutical Company

{pdf_link}

Isotretinoin Acknowledgement of Risk Form

{healthcare_pro_orange} For Healthcare Professionals

Isotretinoin Acknowledgement of Risk Form


{pdf_link}

Patient Reminder Card-Isotretinoin

Patient Reminder Card for Isotretinoin


{pdf_link}

Pharmacist checklist-Isotretinoin

{healthcare_pro_orange} For Healthcare Professionals

Pharmacist Checklist Guidance for Dispensing Oral Isotretinoin


Roaccutane

Neon Healthcare Ltd

{pdf_link}

Isotretinoin Acknowledgement of Risk Form

Acknowledgement of Risk Form for Prescribing Isotretinoin to all Patients.


{pdf_link}

Patient Reminder Card for Isotretinoin

Patient Reminder Card for Isotretinoin containing Important Reminders for Patients


{pdf_link}

Pharmacist Checklist Guidance for Dispensing Oral Isotretinoin

{healthcare_pro_orange} For Healthcare Professionals

Guidance for the Pharmacist when Dispensing Oral Isotretinoin


You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?